Neutralisation capacity against SARS-CoV-2 ancestral, Delta and Omicron variants before and after heterologous booster vaccination in Fijian health system workers
Clicks: 2
ID: 321525
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #349 of 431 articles by views in The Journal of infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 431 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Immunogenicity studies of booster doses of COVID-19 vaccines from Pacific Island countries are limited. A prospective cohort study was conducted amongst healthcare workers in Fiji to assess antibody neutralisation capacity against ancestral, Delta and Omicron (BA.2) variants following high force of infection from Delta during administration of primary dose schedules. Findings showed high baseline neutralisation prior to heterologous booster vaccinations and enduring protective neutralisation against all three variants of SARS-CoV2 at 6 months following booster receipt. Limited benefit from third doses in this population emphasises the need for pragmatic vaccination strategies guided by local disease contexts.
| Reference Key |
openalex_W7169541090
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Anaseini Ratu, Isireli Rabukawaqa, Reuben McGregor, J Sassen, Naina Cagi, Kitione Veitogavi, Venina Naigulevu, Reapi Seru, Luse Lauci, Ciara Ramiah, Lauren H. Carlton, Shalini Singh, Litiana Volavola, Rachel Devi, Donald Wilson, Nicole J. Moreland, Philip C Hill |
| Journal | The Journal of infectious diseases |
| Year | 2026 |
| DOI |
10.1093/infdis/jiag363
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.